Evidence map›Paper›PMID 23516134›Full record

ArticleFrontiers in genetics2013

The two halves of U-shaped mortality.

Daniel A Levitis, Daniel E Martínez

Abstract read
In one paragraph

Article in Frontiers in genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Compression of Morbidity and Mortality: New Perspectives.North American actuarial journal : NAAJ · 2016
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daniel A LevitisMax-Planck Odense Center on the Biodemography of Aging Odense, Denmark ; Institute of Biology, University of Southern Denmark Odense, Denmark.
Daniel E Martínez

Funding

Mechanisms underlying lack of senescence and inducible senescence in members of tR01AG037965 · NIA · POMONA COLLEGE · PI MARTINEZ, DANIEL E. · 2010 to 2014
$1.2M
NIA NIH HHS R01 AG037965
6 · The paper itself

Abstract

Gerontology focuses on deterioration with increasing age, but in most populations most variables, including survival probability, improve at early ages (ontogenescence) before deteriorating at advanced ages (senescence). The extent to which gerontology needs to consider this U-shaped pattern of risk over age depends upon the mechanistic, demographic and evolutionary links and interactions between ontogenescence and senescence. In reading the literature on both senescence and ontogenescence, and in interacting with other biogerontologists, we have encountered a set of what we view as inaccurate or oversimplified claims about ontogenescence, its relationship to senescence and its importance to gerontology. Here, after briefly introducing ontogenescence, we address four of these claims. We demonstrate the counterfactual nature of Claim 1. Ontogenescence is an environmental effect largely absent in protected environments. We then briefly review the literature which leads to Claim 2. Senescence and ontogenescence are parts of the same phenomenon, and describe why we reject this view. We then explain why the rejection of Claim 2 does not necessarily support Claim 3, the idea that senescence and ontogenescence are easily separable. Finally, we examine Claim 4. Gerontologists don't need to think about ontogenescence, and give some examples of why we consider this misguided.

Indexed as

evolutionary demographylife-historymortality patternsontogenescencesenescence

Identifiers

PMID23516134
PMCPMC3601328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.